Document is current

Article History

Received: 26 June 2025

Accepted: 14 September 2025

First Online: 22 September 2025

Declarations

:

: AGOL is the past President of the Pacific Dermatology Association and serves as an associate editor for Dermatology (Karger) and editorial board member of the American Journal of Clinical Dermatology . AGOL was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Additionally, he is a consultant for Genentech and Guidepoint and an advisor to Bristol Meyer Squibb, Boehringer Ingelheim and Janssen. Dr Ortega has received research grants from Eli Lilly, Janssen, Incyte and Pfizer. He is supported by NIH NIAMS R01 AR083110. The other authors have no conflicts of interest to disclose.

: Consent for participation in research was obtained for all study subjects prior to study enrollment.

: Consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and included at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available.

: Not applicable.

: Our study received Institutional Review Board approval from Oregon Health and Science (Study 16753).

: The data that support the findings of this study are available from the corresponding author upon reasonable request.

: AGOL conceived the study. SLB conducted data analysis and visualization. KD and JN performed secondary data analysis and made key contributions to visualization. All authors participated in writing and reviewing the manuscript. AGOL supervised the project.